Filing Details
- Accession Number:
- 0000950170-25-088878
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-23 13:50:13
- Reporting Period:
- 2025-06-20
- Filing Date:
- 2025-06-23
- Accepted Time:
- 2025-06-23 13:50:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1515673 | Ultragenyx Pharmaceutical Inc. | RARE | Pharmaceutical Preparations (2834) | 272546083 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1796536 | D. (Corsee) Corazon Sanders | C/O Ultragenyx Pharmaceutical Inc. 60 Leveroni Court Novato CA 94949 | No | No | No | No |
Transaction Summary
Sold: | 2,405 shares | Avg. Price: $37.39 | Total Value: $89,922.95 |
Number of Shares After Transactions: | 15,344 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-06-20 | 2,405 | $37.39 | 15,344 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |